|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6800 NOK | -15.00% |
|
+3.03% | -50.72% |
| Jun. 30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Jun. 26 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
| Market Cap | 50.61M 5.32M 4.6M 4.29M 3.95M 7.45M 506M 7.54M 50.44M 19.8M 253M 19.97M 19.53M 838M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 26.7M 2.8M 2.43M 2.26M 2.08M 3.93M 267M 3.98M 26.61M 10.44M 133M 10.53M 10.3M 442M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -15.00% | ||
| 1 week | +3.03% | ||
| Current month | -2.86% | ||
| 1 month | -9.33% | ||
| 3 months | -51.43% | ||
| 6 months | -64.21% | ||
| Current year | -50.72% |
| 1 week | 0.67 |  | 0.8 |
| 1 month | 0.64 | | 0.88 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 2.98 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 24 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2018-06-21 | |
Anders Wold
CHM | Chairman | - | 2022-06-07 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/4/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.00% | +3.03% | -76.39% | -93.87% | 5.3M | |
| +0.90% | -2.33% | +0.68% | +14.52% | 48B | |
| +1.59% | +8.73% | +412.41% | +563.68% | 41.13B | |
| +3.70% | -4.65% | +28.33% | +7.63% | 37.56B | |
| +2.04% | +0.92% | +7.49% | +76.10% | 35.91B | |
| +2.42% | +7.27% | +14.90% | +44.79% | 29.86B | |
| +0.34% | -2.52% | - | - | 16.12B | |
| +1.22% | -0.67% | +33.17% | +123.13% | 16.05B | |
| +1.25% | +1.52% | +4.62% | +18.66% | 13.76B | |
| +4.72% | -8.25% | -1.51% | -35.02% | 12.1B | |
| Average | +0.28% | +0.10% | +47.08% | +79.96% | 25.05B | |
| Weighted average by Cap. | +1.88% | -1.29% | +82.56% | +128.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.59 0.01 0.06 0.02 0.29 0.02 0.02 0.98 |
| Net income | -52.33M -5.5M -4.76M -4.44M -4.08M -7.71M -523M -7.79M -52.16M -20.47M -262M -20.65M -20.19M -866M | -86.97M -9.14M -7.91M -7.38M -6.78M -12.81M -869M -12.95M -86.68M -34.02M -435M -34.31M -33.56M -1.44B |
| Net Debt | -98.89M -10.39M -9M -8.39M -7.71M -14.56M -988M -14.73M -98.56M -38.68M -494M -39.02M -38.16M -1.64B | -23.91M -2.51M -2.18M -2.03M -1.87M -3.52M -239M -3.56M -23.83M -9.35M -120M -9.43M -9.23M -396M |
Employees
11
Calendar
Sep. 02
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | NOK 0.6800 | -15.00% | 54,312 |
| 26-08-04 | NOK 0.8000 | 0.00% | 0 |
| 26-08-03 | NOK 0.8000 | +14.29% | 30,250 |
| 26-07-31 | NOK 0.7000 | +4.48% | 25 |
| 26-07-30 | NOK 0.6700 | +1.52% | 1,000 |
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
